Isabella Harumi Yonehara Noma
Overview
Explore the profile of Isabella Harumi Yonehara Noma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
30
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Noma I, Carvalho L, Camarena D, Silva R, Moraes Junior M, de Souza S, et al.
Biomed Pharmacother
. 2024 Jul;
177:116953.
PMID: 38955087
The second most common mutation in melanoma occurs in NRAS oncogene, being a more aggressive disease that has no effective approved treatment. Besides, cellular plasticity limits better outcomes of the...
2.
Carvalho L, Noma I, Uehara A, Siena A, Osaki L, Mori M, et al.
Antioxidants (Basel)
. 2024 May;
13(5).
PMID: 38790661
Microenvironment and transcriptional plasticity generate subpopulations within the tumor, and the use of BRAF inhibitors (BRAFis) contributes to the rise and selection of resistant clones. We stochastically isolated subpopulations (C1,...
3.
Noronha N, Noma I, Fernandes Ferreira R, da Silva Rodrigues G, Martins L, Watanabe L, et al.
Front Nutr
. 2024 Apr;
11:1373499.
PMID: 38638293
Introduction: There is an emerging body of evidence that vitamin C consumption can modulate microbiota abundance and can also impact DNA methylation in the host, and this could be a...
4.
da Silva Rodrigues G, Noronha N, Noma I, de Lima J, da Silva Sobrinho A, Augusta de Souza Pinhel M, et al.
Exp Gerontol
. 2024 Jan;
186:112362.
PMID: 38232788
Exercise training emerges as a key strategy in lifestyle modification, capable of reducing the risk of developing Alzheimer's disease (AD) due to risk factors such as age, family history, genetics...
5.
Watanabe L, Pereira V, Noronha N, Augusta de Souza Pinhel M, Wolf L, de Oliveira C, et al.
J Trace Elem Med Biol
. 2024 Jan;
83:127376.
PMID: 38183920
Introduction: The increasing prevalence of obesity has become a major health problem worldwide. The causes of obesity are multifactorial and could be influenced by dietary patterns and genetic factors. Obesity...
6.
Franco Y, de Moraes Jr M, Carvalho L, Dohle W, da Silva R, Noma I, et al.
Int J Mol Sci
. 2023 Jul;
24(14).
PMID: 37511073
The endogenous estradiol derivative 2-Methoxyestradiol (2-ME) has shown good and wide anticancer activity but suffers from poor oral bioavailability and extensive metabolic conjugation. However, its sulfamoylated derivative, 2-methoxyestradiol-3,17-,-bis-sulfamate (STX140), has...
7.
da Silva Rodrigues G, Noma I, Noronha N, Watanabe L, da Silva Sobrinho A, de Lima J, et al.
Res Q Exerc Sport
. 2023 Jul;
95(2):405-415.
PMID: 37466924
: The acceleration of epigenetic age is a predictor of mortality and contributes to the increase in chronic diseases. Adherence to a healthy lifestyle is a strategy to reduce epigenetic...
8.
Noronha N, da Silva Rodrigues G, Noma I, Brandao C, Rodrigues K, Bruno A, et al.
Front Endocrinol (Lausanne)
. 2022 Sep;
13:895489.
PMID: 36046788
Background: Pre-diabetes precedes Diabetes Mellitus (DM) disease and is a critical period for hyperglycemia treatment, especially for menopausal women, considering all metabolic alterations due to hormonal changes. Recently, the literature...
9.
Noronha N, da Silva Rodrigues G, Augusta de Souza Pinhel M, Cazier J, Watanabe L, Menezes A, et al.
J Vis Exp
. 2022 May;
(183).
PMID: 35604163
Obesity is directly connected to lifestyle and has been associated with DNA methylation changes that may cause alterations in the adipogenesis and lipid storage processes contributing to the development of...
10.
E Silva J, Pereira Vasconcelos A, Noma I, Noronha N, Aquino R, Giddaluru J, et al.
Clin Nutr ESPEN
. 2021 Jul;
44:475-478.
PMID: 34330510
Background & Aims: Obesity is associated with low grade systemic inflammation and insulin resistance. Although metabolic and immunological changes may contribute to the increased risk for COVID-19 mortality in obese,...